Abstracts for oral presentations should be submitted by March 9, 2026. AATCC reserves the right to accept, place on a waiting ...

EFLM recognizes Babson Diagnostics for innovations in sample collection and preparation AUSTIN, TX / ACCESS Newswire / December 18, 2025 / Babson Diagnostics, a science-first healthcare technology ...

Hematologists and oncologists from UC San Francisco shared research results and clinical guidance at the world’s premier meeting for malignant and non-malignant hematology at the American Society of ...

Olimpia works with her father on one of her projects, Clodomiro. "Me and my dad casually came up with the idea of doing a ...

Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings Breadth of Scientific ...

Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced its abstract has been ...

Amplia Therapeutics Limited (ASX:ATX; OTCQB:INNMF) ('Amplia” or the 'Company”) is pleased to announce that the Company’s CMO Dr Jason Lickliter will present a poster at the forthcoming ASCO ...

Vision statements inspire, but tension drives execution. Learn why great strategies start by naming the friction they exist ...

AI companies of all sizes are experimenting. The startup Cursor, an AI coding platform, has been hosting pop-up “Cafe Cursor” ...

Contributions on the topics listed above are welcome as poster presentations. All submissions, apart from invited papers, must present original work, which has not been published elsewhere. In ...

Our top 5 highlights from the 2025 San Antonio Breast Cancer Symposium (SABCS) include articles and interviews introducing ...

Achieving equitable access to anti-fibrotic drugs requires multi-stakeholder collaboration, while the most critical unmet ...